Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H15N2O13P3 |
Molecular Weight | 464.153 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CN([C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C=C2)C(=O)NC1=O
InChI
InChIKey=ODSQODTUNULBHF-JGVFFNPUSA-N
InChI=1S/C10H15N2O13P3/c1-6-4-12(10(14)11-9(6)13)8-3-2-7(23-8)5-22-27(18,19)25-28(20,21)24-26(15,16)17/h2-4,7-8H,5H2,1H3,(H,18,19)(H,20,21)(H,11,13,14)(H2,15,16,17)/t7-,8+/m0/s1
Molecular Formula | C10H15N2O13P3 |
Molecular Weight | 464.153 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:09:37 GMT 2023
by
admin
on
Sat Dec 16 10:09:37 GMT 2023
|
Record UNII |
1ZP0VJ751G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1ZP0VJ751G
Created by
admin on Sat Dec 16 10:09:37 GMT 2023 , Edited by admin on Sat Dec 16 10:09:37 GMT 2023
|
PRIMARY | |||
|
DB02887
Created by
admin on Sat Dec 16 10:09:37 GMT 2023 , Edited by admin on Sat Dec 16 10:09:37 GMT 2023
|
PRIMARY | |||
|
DTXSID10180822
Created by
admin on Sat Dec 16 10:09:37 GMT 2023 , Edited by admin on Sat Dec 16 10:09:37 GMT 2023
|
PRIMARY | |||
|
26194-89-8
Created by
admin on Sat Dec 16 10:09:37 GMT 2023 , Edited by admin on Sat Dec 16 10:09:37 GMT 2023
|
PRIMARY | |||
|
65355
Created by
admin on Sat Dec 16 10:09:37 GMT 2023 , Edited by admin on Sat Dec 16 10:09:37 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
|
||
|
PARENT -> METABOLITE ACTIVE |
The in vitro MIC (50% inhibitory concentration [IC50]) of d4T-TP against HIV-1 has been found to be between 0.009 and 6 μM, depending on the phenotypic and genotypic resistance to nucleoside reverse transcriptase inhibitors.
MAJOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|